BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 27077876)

  • 1. Viral Evasion of Natural Killer Cell Activation.
    Ma Y; Li X; Kuang E
    Viruses; 2016 Apr; 8(4):95. PubMed ID: 27077876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Natural Killer Cell Evasion Through Viral Adaptation.
    Mancini M; Vidal SM
    Annu Rev Immunol; 2020 Apr; 38():511-539. PubMed ID: 32340578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolutionary arms race between NK cells and viruses: who gets the short end of the stick?
    Miletić A; Krmpotić A; Jonjić S
    Eur J Immunol; 2013 Apr; 43(4):867-77. PubMed ID: 23440773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral inhibitors of NKG2D ligands for tumor surveillance.
    Chávez-Blanco A; Chacón-Salinas R; Dominguez-Gomez G; Gonzalez-Fierro A; Perez-Cardenas E; Taja-Chayeb L; Trejo-Becerril C; Duenas-Gonzalez A
    Expert Opin Ther Targets; 2016 Nov; 20(11):1375-1387. PubMed ID: 27322108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of natural killer cells in antiviral immunity.
    Waggoner SN; Reighard SD; Gyurova IE; Cranert SA; Mahl SE; Karmele EP; McNally JP; Moran MT; Brooks TR; Yaqoob F; Rydyznski CE
    Curr Opin Virol; 2016 Feb; 16():15-23. PubMed ID: 26590692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesvirus Evasion of Natural Killer Cells.
    De Pelsmaeker S; Romero N; Vitale M; Favoreel HW
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudorabies Virus US3 Protein Kinase Protects Infected Cells from NK Cell-Mediated Lysis via Increased Binding of the Inhibitory NK Cell Receptor CD300a.
    Grauwet K; Vitale M; De Pelsmaeker S; Jacob T; Laval K; Moretta L; Parodi M; Parolini S; Cantoni C; Favoreel HW
    J Virol; 2016 Feb; 90(3):1522-33. PubMed ID: 26581992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.
    Magri G; Muntasell A; Romo N; Sáez-Borderías A; Pende D; Geraghty DE; Hengel H; Angulo A; Moretta A; López-Botet M
    Blood; 2011 Jan; 117(3):848-56. PubMed ID: 21030563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
    Cifaldi L; Doria M; Cotugno N; Zicari S; Cancrini C; Palma P; Rossi P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral modulation of NK cell immunity.
    Lodoen MB; Lanier LL
    Nat Rev Microbiol; 2005 Jan; 3(1):59-69. PubMed ID: 15608700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCMV avoidance of recognition and control by NK cells.
    Brizić I; Lenac Roviš T; Krmpotić A; Jonjić S
    Semin Immunopathol; 2014 Nov; 36(6):641-50. PubMed ID: 25141793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells.
    Schmiedel D; Tai J; Levi-Schaffer F; Dovrat S; Mandelboim O
    J Virol; 2016 Nov; 90(21):9608-9617. PubMed ID: 27535049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune evasion of natural killer cells by viruses.
    Jonjić S; Babić M; Polić B; Krmpotić A
    Curr Opin Immunol; 2008 Feb; 20(1):30-8. PubMed ID: 18206359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into activation of antiviral NK cell responses.
    Finton KA; Strong RK
    Immunol Rev; 2012 Nov; 250(1):239-57. PubMed ID: 23046134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Here today--not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections.
    Lee SH; Biron CA
    Eur J Immunol; 2010 Apr; 40(4):923-32. PubMed ID: 20209503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family.
    Aguilar OA; Berry R; Rahim MMA; Reichel JJ; Popović B; Tanaka M; Fu Z; Balaji GR; Lau TNH; Tu MM; Kirkham CL; Mahmoud AB; Mesci A; Krmpotić A; Allan DSJ; Makrigiannis AP; Jonjić S; Rossjohn J; Carlyle JR
    Cell; 2017 Mar; 169(1):58-71.e14. PubMed ID: 28340350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of human natural killer cell receptors in early life.
    Sundström Y; Nilsson C; Lilja G; Kärre K; Troye-Blomberg M; Berg L
    Scand J Immunol; 2007; 66(2-3):335-44. PubMed ID: 17635811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell specificity for viral infections.
    Hammer Q; Rückert T; Romagnani C
    Nat Immunol; 2018 Aug; 19(8):800-808. PubMed ID: 30026479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells in host responses to viral infections.
    Lam VC; Lanier LL
    Curr Opin Immunol; 2017 Feb; 44():43-51. PubMed ID: 27984782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.